Treatment of infertility with hypogonadotropic hypogonadism: 10-Year experience in Auckland, New Zealand

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 52, Issue 3, 2012, Pages 293-298

  Milsom, Stella ^a,b   Duggan, Kate ^c   O'Sullivan, Susannah ^a,d   Ogilvie, Megan ^a,b   Gunn, Alistair Jan ^d  

^a Ascot Integrated Hospital   (New Zealand)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

^c TAURANGA HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Assisted reproductive technology; Gonadotropin therapy; Hypogonadotropic hypogonadism; Infertility; Kallman's syndrome

Indexed keywords

GONADOTROPIN;

ADULT; ARTICLE; ASSISTED REPRODUCTIVE TECHNOLOGY; CLINICAL ARTICLE; CONCEPTION; DISEASE ASSOCIATION; FEMALE; FEMALE INFERTILITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LIVE BIRTH; MALE; MALE INFERTILITY; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; TREATMENT OUTCOME;

ADULT; FEMALE; GONADOTROPINS; HUMANS; HYPOGONADISM; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; MIDDLE AGED; NEW ZEALAND; PREGNANCY; PREGNANCY RATE; SEX FACTORS;

EID: 84862577155     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2012.01450.x     Document Type: Article

References (18)

1. Matsumoto AM, Snyder PJ, Bhasin S et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril 2009; 92: 979-990.
2. Yang L, Zhang SX, Dong Q et al. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol 2011; 44: 393-399.
3. Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991; 56: 1048-1053.
4. Burgues S. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod 2001; 16: 2525-2532. (Pubitemid 34007466)
5. Cooper TG, Noonan E, von Eckardstein S et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16: 231-245.
6. Warne DW, Decosterd G, Okada H et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril 2009; 92: 594-604.
7. Farhat R, Al-zidjali F, Alzahrani AS. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary 2010; 13: 105-110.
8. Miyagawa Y, Tsujimura A, Matsumiya K et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 2005; 173: 2072-2075. (Pubitemid 40675246)
9. Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 1988; 66: 1144-1151.
10. Liu PY, Baker HW, Jayadev V et al. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab 2009; 94: 801-808.
11. Bakircioglu ME, Erden HF, Ciray HN et al. Gonadotrophin therapy in combination with ICSI in men with hypogonadotrophic hypogonadism. Reprod Biomed Online 2007; 15: 156-160. (Pubitemid 47263323)
12. Resorlu B, Abdulmajed MI, Kara C et al. Is intracytoplasmic sperm injection essential for the treatment of hypogonadotrophic hypogonadism? A comparison between idiopathic and secondary hypogonadotrophic hypogonadism. Hum Fertil (Camb) 2009; 12: 204-208.
13. Zorn B, Pfeifer M, Virant-Klun I, Meden-Vrtovec H. Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism. Int J Androl 2005; 28: 202-207. (Pubitemid 41075937)
14. Shoham Z, Smith H, Yeko Tet al. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol (Oxf) 2008; 69: 471-478.
15. Messinis IE, Milingos S, Zikopoulos K et al. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone. Hum Reprod 1998; 13: 2415-2420. (Pubitemid 28451216)
16. Kaufmann R, Dunn R, Vaughn T et al. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. Clin Endocrinol (Oxf) 2007; 67: 563-569. (Pubitemid 47416315)
17. O'Dea L, O'Brien F, Currie K, Hemsey G. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect. Curr Med Res Opin 2008; 24: 2785-2793.
18. Burgues S, Calderon MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on male hypogonadotropic hypogonadism. Hum Reprod 1997; 12: 980-986. (Pubitemid 27271756)